glp-1 makers are glp- 1 being sued ad war leads to lawsuit by Novo Nordisk, claiming Eli Lilly misleads Looming GLP-1 drug patent expirations – glp-1 drug makers Agonists Market

But the researchers point out that the clinical trials for GLP-1 drugs excluded people with mood disorders and a history of suicide attempts leaving out those with bipolar disorder

One way to tackle the issue is to reduce exposure by making injections even less frequent

SC: Conceptualization, Formal Analysis, Investigation, Methodology, Visualization, Writing original draft, Writing review & editing

Selecting and matching to patients whose characteristics mimic those of people initiating insulin can provide a proxy for a more progressed cohort of patients with T2D

Byetta can be used in an adjunctive therapy for glycemic control

Evaluation of the forced inspiratory suction and swallow tool to stop hiccups